PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 172 filers reported holding PDL BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 500 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | -84.6% | 500 | -85.7% | 0.00% | -100.0% |
| Q1 2019 | $13,000 | +30.0% | 3,500 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $10,000 | +11.1% | 3,500 | 0.0% | 0.00% | +100.0% |
| Q3 2018 | $9,000 | +12.5% | 3,500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $8,000 | -20.0% | 3,500 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $10,000 | +11.1% | 3,500 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $9,000 | -25.0% | 3,500 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $12,000 | +50.0% | 3,500 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $8,000 | 0.0% | 3,500 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $8,000 | +14.3% | 3,500 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $7,000 | -41.7% | 3,500 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $12,000 | +9.1% | 3,500 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $11,000 | +450.0% | 3,500 | +600.0% | 0.00% | +200.0% |
| Q1 2016 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | -50.0% |
| Q4 2014 | $4,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $4,000 | -20.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $5,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |